These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22308054)

  • 1. The efficacy of licorice root extract in decreasing transaminase activities in non-alcoholic fatty liver disease: a randomized controlled clinical trial.
    Hajiaghamohammadi AA; Ziaee A; Samimi R
    Phytother Res; 2012 Sep; 26(9):1381-4. PubMed ID: 22308054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial.
    Aller R; De Luis DA; Izaola O; Conde R; Gonzalez Sagrado M; Primo D; De La Fuente B; Gonzalez J
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1090-5. PubMed ID: 22013734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
    Lee MH; Kim YM; Kim SG
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
    Askari F; Rashidkhani B; Hekmatdoost A
    Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical observation on acupoint catgut embedding for treatment of non-alcoholic steatohepatitis].
    Liu XD; Wang M; Li YZ
    Zhongguo Zhen Jiu; 2010 Aug; 30(8):637-41. PubMed ID: 20942279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin.
    Gonciarz M; Gonciarz Z; Bielanski W; Mularczyk A; Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2010 Dec; 61(6):705-10. PubMed ID: 21224501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial.
    Kohler M; Pepperell JC; Davies RJ; Stradling JR
    Respiration; 2009; 78(2):141-6. PubMed ID: 18984944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of Yiqi Sanju Formula on non-alcoholic fatty liver disease: a randomized controlled trial].
    Lou SY; Liu Y; Ma YY; Chen HY; Chen WH; Ying J; He YM; Wang WJ
    Zhong Xi Yi Jie He Xue Bao; 2008 Aug; 6(8):793-8. PubMed ID: 18664346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
    Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease.
    Das KS; Balakrishnan V; Mukherjee S; Vasudevan DM
    Scand J Clin Lab Invest; 2008; 68(4):323-34. PubMed ID: 18609067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
    Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
    Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
    Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
    Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance.
    de Luis DA; Aller R; Izaola O; Sagrado MG; Conde R; Gonzalez JM
    Diabetes Res Clin Pract; 2008 Jan; 79(1):74-8. PubMed ID: 17766001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
    Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
    Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.
    Verrijken A; Francque S; Mertens I; Talloen M; Peiffer F; Van Gaal L
    Int J Obes (Lond); 2010 May; 34(5):899-907. PubMed ID: 20142825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.